Literature DB >> 10481973

Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency (CRI).

E Kimak1, J Solski, L Janicka, M Zagojska.   

Abstract

The serum levels of lipids, apolipoproteins and lipoprotein ratios in 19 healthy persons and 20 patients with uraemia not dialyzed were determined. Based on creatinine level the patients were divided into two groups: L (serum creatinine 2-5 mg/dl) and H (serum creatinine 5-10 mg/dl). Dyslipoproteinaemia in uraemic patients is already manifested in the early stages of the disease through its abnormal apolipoproteins rather than lipid profile and it suggests a high risk of atherosclerosis.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10481973     DOI： 10.1023/a:1007145329360

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  14 in total

Review 1.  Lipid abnormalities in chronic renal insufficiency.

Authors:  P O Attman; P Alaupovic
Journal:  Kidney Int Suppl       Date:  1991-04       Impact factor: 10.545

Review 2.  Lipid abnormalities in renal disease.

Authors:  G Appel
Journal:  Kidney Int       Date:  1991-01       Impact factor: 10.612

Review 3.  Hyperlipoproteinaemia in renal failure: pathogenesis and perspectives for intervention.

Authors:  P O Attman
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

4.  Effect of dialysis membranes on lipoprotein profile of serum in haemodialysed patients.

Authors:  E Kimak; J Solski; L Janicka; B Wojtysiak; M Zagojska
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

5.  Plasma lipoproteins in patients with chronic renal failure (CRF).

Authors:  E Kimak; J Solski; L Janicka; D Duma; M Zagojska
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

6.  Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.

Authors:  P O Attman; P Alaupovic
Journal:  Nephron       Date:  1991       Impact factor: 2.847

7.  Correlation between the ratio of serum low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with that of serum apolipoproteins B and A-I.

Authors:  S Väisänen; J Gävert; A Julkunen; E Voutilainen; I Penttilä
Journal:  Int J Clin Lab Res       Date:  1993

8.  Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy.

Authors:  A M Dnistrian; M K Schwartz; E J Greenberg; C A Smith; D C Schwartz
Journal:  Clin Chim Acta       Date:  1993-12-31       Impact factor: 3.786

9.  Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency.

Authors:  O Samuelsson; M Aurell; C Knight-Gibson; P Alaupovic; P O Attman
Journal:  Nephron       Date:  1993       Impact factor: 2.847

10.  Lipoproteins and apolipoproteins during the progression of chronic renal disease.

Authors:  P Grützmacher; W März; B Peschke; W Gross; W Schoeppe
Journal:  Nephron       Date:  1988       Impact factor: 2.847
View more
  3 in total

Review 1.  Urea and atherosclerosis--evidence for a direct link involving apolipoprotein B protein modifications.

Authors:  Christian Albert; Peter R Mertens; Peter Bartsch
Journal:  Int Urol Nephrol       Date:  2011-05-19       Impact factor: 2.370

2.  Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study.

Authors:  Joachim H Ix; Michael G Shlipak; Haiying H Liu; Nelson B Schiller; Mary A Whooley
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

3.  Genetic variation of apolipoprotein E does not contribute to the lipid abnormalities secondary to childhood minimal change nephrotic syndrome.

Authors:  Peng Hu; Yuan Han Qin; Ling Lu; Bo Hu; Cheng Xue Jing; Feng Ying Lei; Ming Fang Li
Journal:  Int Urol Nephrol       Date:  2009-02-25       Impact factor: 2.370
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.